Daily Morning Note – 23 November 2021


The S&P 500 ended lower and the Nasdaq tumbled deep into negative territory on Monday after both earlier hit record highs following the announcement of a second term for Federal Reserve Chair Jerome Powell. The Dow Jones Industrial Average ended slightly higher. Climbing Treasury yields kept tech stocks broadly lower, with holdouts including Microsoft and Apple, which many investors view as relatively safe, giving up gains late in the session. The Dow Jones Industrial Average rose 0.05 per cent to end at 35,619.25 points, while the S&P 500 lost 0.32 per cent to 4,682.94. The Nasdaq Composite dropped 1.26 per cent to 15,854.76.

Local shares began the week on a more upbeat showing, as Singapore further eased its Covid-19 restrictions related to dining and social gatherings amid an improvement in overall infection numbers. Investors appeared slightly more optimistic, with the benchmark Straits Times Index gaining 0.2 per cent or 4.74 points to cap off Monday at 3,237.08. Across the broader market, however, decliners surged past advancers 282 to 190, after some 1.7 billion securities worth S$936.5 million changed hands.



Global offshore group Keppel FELS has landed a contract from a renewable energy company to construct two offshore substations worth around S$110 million. The project is scheduled to be completed in 2024, to be deployed in an offshore wind farm. Keppel FELS, a wholly-owned subsidiary of Keppel Offshore & Marine (Keppel O&M), said in a bourse filing on Monday that its work scope comprises the engineering, procurement, construction, testing and comissioning for the topside modules of the two offshore substations. This excludes the offshore substations’ foundations and electrical components that will be furnished by the client.

Temasek has received valid applications of more than 6 times the amount available in its 5-year Singapore dollar bond issue. The retail tranche of the offering drew S$649.5 million in applications, when the public offer closed at noon on Monday (Nov 22). The offer of the T2026-S$ Temasek Bond, issued via its wholly-owned subsidiary Temasek Financial (IV), comprises 1.8 per cent fixed rate guaranteed notes due 2026. An allocation process will take place following the closure of the offer, with its results expected by the evening of Nov 23. Temasek had said it would take into account the investor demand from applications received before deciding on the final allocation approach. This is the second Temasek bond with a retail tranche. The last time it did so was in 2018 with the 5-year T2023-S$ Temasek Bond, which closed at a fixed interest rate of 2.7 per cent per annum.

Catalist-listed protective gear manufacturer Medtecs International Corp reported a 77 per cent slide in net profit for the 9 months ended September 2021 to US$19.26 million, as demand for personal protective equipment fell. Stock-piling exercises for existing customers in 2020 have completed, while the supply and prices of the personal protective equipment (PPE) market have stabilised globally, the group said in a business update filed with the Singapore Exchange on Monday (Nov 22). In a separate update on its joint venture with US healthcare market player ACO International, Medtecs said its wholly-owned subsidiary Medtecs (Asia Pacific) and ACO are in discussions to enter into a share subscription agreement. Following an initial capital injection, the joint venture company Resilient Medical will have an initial issued and paid-up capital of US$9 million comprising 6 million ordinary shares held by Medtecs (Asia Pacific) and 3 million ordinary shares held by ACO.


Sales of previously owned US homes rose unexpectedly in October to the highest level since the start of the year, pointing to healthy demand as more buyers take advantage of stronger job growth and low mortgage rates. Contract closings increased 0.8 per cent from the prior month to an annualised 6.34 million, figures from the National Association of Realtors showed Monday. The median forecast in a Bloomberg survey of economists called for a 6.2 million pace in October. While the monthly pace of sales has settled back after reaching a 14-year high a year ago, they remain well above pre-pandemic levels. Sales are on track to exceed 6 million this year, which would be the strongest since 2006.

President Joe Biden selected Jerome Powell for a second four-year term as US Federal Reserve chair and elevated Governor Lael Brainard to vice-chair, maintaining consistency at the central bank as it grapples with the fastest inflation in three decades, along with the lingering effects of the coronavirus pandemic. The move, announced by the White House on Monday, rewards Powell for helping rescue the US economy from the pandemic and tasks him with protecting that recovery from a surge in consumer prices. A Republican, Powell faces what will likely be a smooth confirmation in the Senate, where he was backed for his first term as chair in an 84-13 vote and whose members he subsequently worked hard to woo. Brainard replaces Richard Clarida in the vice-chair slot and may face opposition from Senate Republicans for her confirmation. She was interviewed by Biden for the chair position and was seen as a strong contender for the separate job of vice-chair for supervision, which remains vacant.

Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, CNBC, PSR

Technical Pulse: Keppel Corp Ltd

Recommended: Technical BUY; Analyst: Chua Wei Ren

Keppel Corp (SGX: BN4) Failure to break the gap resistance zone in October caused the price to fall sharply. But the positive outlook is because the price managed to remain above the resistance turned support at $5.30

Buy spot: 5.39 Stop loss: 5.05 Take profit 1: 6.00 Take profit 2: 7.01

Technical Pulse: Straits Trading Co/Ltd

Recommended: Technical BUY; Analyst: Chua Wei Ren

Straits Trading Co/Ltd (SGX: S20) Impulse bullish upside is set to return after a slight correction

Buy stop: 3.54 Stop loss: 3.20 Take profit 1: 3.90 Take profit 2: 4.20

POEMS Podcast: Let the Money Talk

Recent Podcasts:

Daily Morning Note – November 22,2021

Daily Morning Note – November 19, 2021

Daily Morning Note – November 18, 2021

Visit www.stocksbnb.com to learn more!

Join our Phillip Securities Research Telegram channel for the latest update on our stock coverage!

Click here to join: https://t.me/stocksbnb

Webinar Of The Week

Weekly Market Outlook: Keppel Corp, UMS Holdings, UG Healthcare, Hyphens Pharma, Q&M Dental Group…

Date: 22 November 2021

For more on Market Outlook

Updates summarised in 3 minutes

Phillip Research in 3 minutes: #29 Keppel Corporation; Initiation

For more videos on Phillip in 3 Mins

Read the research report(s), available through the link(s) above, for complete information including important disclosures Important Information

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.


Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com